Pacific Shuanglin Bio pharmacy Co Ltd (000403) — Financial Flexibility Index
Pacific Shuanglin Bio pharmacy Co Ltd (000403) has a Financial Flexibility Index of 0.09x as of September 2025. Free cash flow of CN¥142.45 Million (operating CF CN¥70.28 Million minus capex CN¥72.17 Million) represents 0% of total liabilities (CN¥1.55 Billion). Check 000403 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Pacific Shuanglin Bio pharmacy Co Ltd Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Pacific Shuanglin Bio pharmacy Co Ltd across 28 annual periods. For the full cash flow conversion analysis, see how efficiently does Pacific Shuanglin Bio pharmacy Co Ltd generate cash.
Annual Financial Flexibility Index for Pacific Shuanglin Bio pharmacy Co Ltd (1998–2025)
Year-by-year free cash flow to debt coverage for Pacific Shuanglin Bio pharmacy Co Ltd. Explore cash flow to debt ratio of Pacific Shuanglin Bio pharmacy Co Ltd to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.08x | CN¥117.41 Million | CN¥-215.99 Million | CN¥1.39 Billion | ▼ -86.6% |
| 2024 | 0.63x | CN¥842.50 Million | CN¥321.79 Million | CN¥1.33 Billion | ▼ -27.5% |
| 2023 | 0.87x | CN¥1.06 Billion | CN¥679.01 Million | CN¥1.21 Billion | ▲ +8.5% |
| 2022 | 0.81x | CN¥902.86 Million | CN¥524.22 Million | CN¥1.12 Billion | ▼ -16.7% |
| 2021 | 0.97x | CN¥734.38 Million | CN¥408.22 Million | CN¥760.07 Million | ▲ +181.9% |
| 2020 | 0.34x | CN¥235.02 Million | CN¥194.84 Million | CN¥685.71 Million | ▼ -30.5% |
| 2019 | 0.49x | CN¥231.96 Million | CN¥190.84 Million | CN¥470.04 Million | ▲ +127.2% |
| 2018 | 0.22x | CN¥151.65 Million | CN¥116.63 Million | CN¥698.08 Million | ▲ +4079.0% |
| 2017 | 0.01x | CN¥3.96 Million | CN¥-35.91 Million | CN¥761.70 Million | ▼ -97.7% |
| 2016 | 0.23x | CN¥160.52 Million | CN¥62.49 Million | CN¥696.41 Million | ▲ +31.5% |
| 2015 | 0.18x | CN¥129.70 Million | CN¥70.31 Million | CN¥739.82 Million | ▼ -13.0% |
| 2014 | 0.20x | CN¥148.09 Million | CN¥77.04 Million | CN¥735.16 Million | ▼ -33.7% |
| 2013 | 0.30x | CN¥254.00 Million | CN¥91.01 Million | CN¥835.47 Million | ▼ -21.8% |
| 2012 | 0.39x | CN¥303.53 Million | CN¥123.24 Million | CN¥780.27 Million | ▲ +29.5% |
| 2011 | 0.30x | CN¥203.72 Million | CN¥130.14 Million | CN¥678.06 Million | ▲ +322.4% |
| 2010 | 0.07x | CN¥46.34 Million | CN¥9.88 Million | CN¥651.42 Million | ▼ -56.5% |
| 2009 | 0.16x | CN¥182.16 Million | CN¥111.86 Million | CN¥1.11 Billion | ▲ +43.2% |
| 2008 | 0.11x | CN¥118.49 Million | CN¥74.90 Million | CN¥1.04 Billion | ▲ +85.9% |
| 2007 | 0.06x | CN¥101.34 Million | CN¥95.03 Million | CN¥1.65 Billion | ▲ +3801.9% |
| 2006 | 0.00x | CN¥-2.88 Million | CN¥-10.42 Million | CN¥1.73 Billion | ▼ -105.8% |
| 2005 | 0.03x | CN¥56.01 Million | CN¥49.06 Million | CN¥1.97 Billion | ▲ +216.0% |
| 2004 | -0.02x | CN¥-37.09 Million | CN¥-131.73 Million | CN¥1.51 Billion | ▼ -132.8% |
| 2003 | 0.07x | CN¥104.70 Million | CN¥-49.47 Million | CN¥1.40 Billion | ▼ -77.0% |
| 2002 | 0.32x | CN¥248.27 Million | CN¥159.18 Million | CN¥765.52 Million | ▲ +12.4% |
| 2001 | 0.29x | CN¥199.24 Million | CN¥111.28 Million | CN¥690.82 Million | ▲ +98.9% |
| 2000 | 0.14x | CN¥83.98 Million | CN¥27.36 Million | CN¥579.29 Million | ▲ +9.6% |
| 1999 | 0.13x | CN¥63.35 Million | CN¥-23.08 Million | CN¥478.92 Million | ▲ +344.3% |
| 1998 | 0.03x | CN¥8.58 Million | CN¥-2.65 Million | CN¥288.28 Million | — |